- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made).
16.—(1) A UK producer who is a medicines wholesaler or an importer must—
(a)record the information mentioned in paragraph (2) for each purchase by the producer of a presentation of imported special health service medicine for supply, and
(b)keep that information for a period of four years beginning with the day on which it is recorded.
(2) The information is—
(a)the name of the person from whom the presentation is purchased,
(b)the quantity of packs purchased,
(c)the net purchase amount, or a reasonable estimate of the net purchase amount, for the purchase,
(d)the terms on which any discounts, payments, or payments or benefits in kind taken into account when calculating that amount were received, and
(e)the name of the person to whom the discounts, payments, or payments or benefits in kind were given, if that person is not the producer.
(3) A UK producer who is a medicines wholesaler or an importer must also—
(a)record the information mentioned in paragraph (4) for each supply of a presentation of imported special health service medicine by the producer, and
(b)keep that information for a period of four years beginning with the day on which it is recorded.
(4) The information is—
(a)the name of the person to whom the presentation is supplied (“the purchaser”),
(b)if known to the producer, whether the purchaser is in Category A, B, C or D,
(c)the quantity of packs supplied,
(d)the net sales income, or a reasonable estimate of the net sales income, for the supply,
(e)the terms on which the discounts, payments, or payments or benefits in kind taken into account when calculating that income were given by the producer,
(f)the name of the person to whom any of those discounts, payments, or payments or benefits in kind were given, if that person is not the purchaser, and
(g)if known to the producer, whether the presentation is an English health service product, a Welsh health service product, a Scottish health service product or a Northern Ireland health service product.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: